Glycogen Storage Disease Type I (von Gierke) Metabolic Monitor

Monitors metabolic stability in Glycogen Storage Disease Type I using glucose, lactate, uric acid, triglycerides, and liver size, with cornstarch dosing optimization.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Monitors metabolic stability in Glycogen Storage Disease Type I using glucose, lactate, uric acid, triglycerides, and liver size, with cornstarch dosing optimization

Each component has a specific meaning:

  • Glucose — The glucose recorded for the scenario being assessed.
  • Lactate — The lactate recorded for the scenario being assessed.
  • Uric acid — The uric acid recorded for the scenario being assessed.
  • Triglycerides — The triglycerides recorded for the scenario being assessed.
  • Liver size — The liver size recorded for the scenario being assessed.

Note: Interpret the gsd-i monitor result against the thresholds and context described above.

How to Use

Enter the glucose, lactate, uric acid, triglycerides, liver size for the scenario you are assessing. Monitors metabolic stability in Glycogen Storage Disease Type I using glucose, lactate, uric acid, triglycerides, and liver size, with cornstarch dosing optimization. Use the gsd-i monitor result to inform your calculation.

Frequently Asked Questions